Most rodent models of PD based on LRRK2 mutations (and those in other genes) demonstrate alterations to nigral dopamine and other synaptic systems, that are likely pertinent to early disease symptoms and potentially progression. The gene discussed is LRRK2; the disease is Parkinson disease.